z-logo
open-access-imgOpen Access
Chronic kidney disease after heart transplantation: a single‐centre retrospective study at Skåne University Hospital in Lund 1988–2010
Author(s) -
Söderlund Carl,
Löfdahl Eveline,
Nilsson Johan,
Reitan Öyvind,
Higgins Thomas,
Rådegran Göran
Publication year - 2016
Publication title -
transplant international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.998
H-Index - 82
eISSN - 1432-2277
pISSN - 0934-0874
DOI - 10.1111/tri.12710
Subject(s) - medicine , renal function , kidney disease , transplantation , incidence (geometry) , cumulative incidence , kidney transplantation , urology , proteinuria , heart transplantation , retrospective cohort study , cardiology , kidney , physics , optics
Summary We aimed to study the incidence, predictors and outcome of chronic kidney disease ( CKD ) after heart transplantation ( HT ). All our HT patients 1988–2010 were considered for inclusion. Of these, 134 came for annual follow‐ups including evaluation of glomerular filtration rate ( GFR ) using iohexol clearance measurements, and the CKD ‐ EPI (adults) or Schwartz (children) formulae. Median GFR (Q1–Q3) (ml/min/1.73 m 2 ) declined from 67.0 (50.0–82.0) during transplant assessment ( TA ) to 56.0 (45.0–69.0) at year 1, 53.0 (41.0–68.0) at year 5 and 44.5 (25.0–57.3) at year 10. The cumulative incidence of CKD ≥ stage 4 was 25% at 5 years and 41% at 10 years after transplantation. Proteinuria the first year post‐ HT was the only predictor related ( P  < 0.05) to a higher rate of GFR decline ( HR 5.15, 95% CI 1.23–21.55). GFR ≥60 as compared to <60 before HT , or a first‐year GFR decline <30% as compared to >30%, was moreover associated ( P  < 0.05) with a lower risk of death ( HR 0.30, 95% CI 0.12–0.76 and HR 0.35, 95% CI 0.13–0.90, respectively). Notably, the CKD ‐ EPI and Schwartz formulae overestimated GFR by 28 ± 29% and 26 ± 33%, respectively. In conclusion, CKD in HT patients is common and associated with worse outcome. To avoid diagnostic delay, GFR estimating equations' validity in HT patients needs further study.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here